Interplay between platelets and coagulation

Y Sang, M Roest, B de Laat, PG de Groot, D Huskens - Blood reviews, 2021 - Elsevier
Haemostasis stops bleeding at the site of vascular injury and maintains the integrity of blood
vessels through clot formation. This regulated physiological process consists of complex …

Circulating platelets as mediators of immunity, inflammation, and thrombosis

M Koupenova, L Clancy, HA Corkrey… - Circulation …, 2018 - Am Heart Assoc
Platelets, non-nucleated blood components first described over 130 years ago, are
recognized as the primary cell regulating hemostasis and thrombosis. The vascular …

Toll-like receptors in immunity and inflammatory diseases: Past, present, and future

K Vijay - International immunopharmacology, 2018 - Elsevier
The immune system is a very diverse system of the host that evolved during evolution to
cope with various pathogens present in the vicinity of environmental surroundings inhabited …

NETosis, complement, and coagulation: a triangular relationship

CM de Bont, WC Boelens, GJM Pruijn - Cellular & molecular …, 2019 - nature.com
NETosis is a regulated form of neutrophil cell death that contributes to the host defense
against pathogens and was linked to various diseases soon after its first description in 2004 …

[HTML][HTML] Platelets in sepsis: an update on experimental models and clinical data

A Assinger, WC Schrottmaier, M Salzmann… - Frontiers in …, 2019 - frontiersin.org
Beyond their important role in hemostasis, platelets play a crucial role in inflammatory
diseases. This becomes apparent during sepsis, where platelet count and activation …

[HTML][HTML] The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases

L Guo, MT Rondina - Frontiers in immunology, 2019 - frontiersin.org
Platelets are anucleate cells produced by megakaryocytes. In recent years, a robust body of
literature supports the evolving role of platelets as key sentinel and effector cells in infectious …

Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment

M Giustozzi, H Ehrlinder, D Bongiovanni, JA Borovac… - Blood reviews, 2021 - Elsevier
Sepsis is a complex syndrome with a high incidence, increasing by 8.7% annually over the
last 20 years. Coagulopathy is a leading factor associated with mortality in patients with …

[HTML][HTML] Biomimetic platelet membrane-coated nanoparticles for targeted therapy

H Han, R Bartolo, J Li, MA Shahbazi… - European Journal of …, 2022 - Elsevier
The development of cell membrane-modified biomimetic nanoparticles has extensively
increased during the past years due to their exceptional biocompatibility, evasion from the …

[HTML][HTML] Sepsis-induced coagulopathy: an update on pathophysiology, biomarkers, and current guidelines

AG Tsantes, S Parastatidou, EA Tsantes, E Bonova… - Life, 2023 - mdpi.com
Significant cross talk occurs between inflammation and coagulation. Thus, coagulopathy is
common in sepsis, potentially aggravating the prognosis. Initially, septic patients tend to …

[HTML][HTML] Platelets are critical key players in sepsis

F Vardon-Bounes, S Ruiz, MP Gratacap… - International journal of …, 2019 - mdpi.com
Host defense against infection is based on two crucial mechanisms: the inflammatory
response and the activation of coagulation. Platelets are involved in both hemostasis and …